---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029599"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-06-22T20:35:33+00:00"
generated_at: "2026-06-22T20:37:40.107110+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma stockholders approve three warrant-related proposals at special meeting

## Summary
- Warrant Issuance Proposal: 1,742,683 for, 107,523 against, 4,818 withheld, 0 non-votes.
- Share Adjustment Proposal: 1,745,709 for, 103,550 against, 5,764 withheld, 0 non-votes.
- Exercise Price Adjustment Proposal: 1,739,702 for, 110,483 against, 4,839 withheld, 0 non-votes.
- All proposals related to warrants on common stock (ASBP) and warrants (ASBPW) under terms of Warrant Agreement dated March 17, 2026.

## SEC filing metadata
- accession: 0001493152-26-029599
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-06-22T20:35:33+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029599
- JSON: https://secwatch.observer/filing/0001493152-26-029599.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029599.txt

## Key facts
- Shareholder Votes
  Aspire Biopharma Holdings, Inc. shareholders approved To approve adjustment of number of shares of common stock issuable upon exercise of warrants (Share Adjustment Proposal) at the 2026-06-16 meeting.
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The number of shares that voted for, against, and withheld from voting for this Share Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,745,709 103,550 5,764 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm
- Shareholder Votes
  Aspire Biopharma Holdings, Inc. shareholders approved To approve voluntary adjustments to the exercise price of the warrants (Exercise Price Adjustment Proposal) at the 2026-06-16 meeting.
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The number of shares that voted for, against, and withheld from voting for this Exercise Price Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,739,702 110,483 4,839 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm
- Shareholder Votes
  Aspire Biopharma Holdings, Inc. shareholders approved To authorize issuance of shares of common stock upon exercise of warrants (Warrant Issuance Proposal) at the 2026-06-16 meeting.
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: The number of shares that voted for, against, and withheld from voting for this Warrant Issuance Proposal is summarized in the table below: Votes Non-Votes 1,742,683 107,523 4,818 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.